Abstract
Purpose
This study aims to compare the economic- and patient-reported outcomes between outpatient home-based and inpatient hospital-based chemotherapy in advanced colorectal cancer patients.
Methods
A total of 80 patients from Severance Hospital in Seoul, Korea, who had stage III colorectal cancer and underwent home-based (n = 40) or hospital-based chemotherapy (n = 40) with a FOLFOX regimen between January 2007 and April 2008 were enrolled. Patient satisfaction data were collected by a self-administered questionnaire survey. Based on hospital charge records, average cost (in 2008 Korean won (KW)) per chemotherapy session was estimated and compared between home- and hospital-based chemotherapy from a societal perspective.
Results
Patients receiving chemotherapy at home showed higher satisfaction with their treatment (mean satisfaction score 3.58 ± 0.15, 5-point Likert-type scale, with a higher score indicating higher satisfaction) than did those treated at the hospital (3.23 ± 0.21; p < 0.01). After adjusting for differences in baseline characteristics between the two groups using multivariate analysis, those receiving home-based chemotherapy still showed significantly higher satisfaction than those undergoing hospital-based therapy (β = 0.271, p < 0.001). Additionally, home-based therapy reduced the cost per chemotherapy session by 16.6%, compared with hospital-based treatment (1,694,216 versus 2,030,383 KW, 1,200 KW ≈ 1 US dollar). The largest cost reduction was attributable to medical costs (−201,122 KW), followed by caregiver’s opportunity costs (−135,000 KW).
Conclusions
Higher satisfaction and lower economic cost for home-based chemotherapy suggests that home-based chemotherapy could be a popular and cost-effective treatment option for colorectal cancer patients who are eligible for home-based chemotherapy.
Similar content being viewed by others
References
Biffi R, de Braud F, Orsi F et al (2001) A randomized, prospective trial of central venous pots connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92:1204–1212
Borras JM, Sanchez-Hernandez A, Navarro M et al (2001) Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomized controlled trial. BMJ 322:1–5
Close P, Burkey E, Kazak A, Danz P, Lange B (1995) A prospective controlled evaluation of home chemotherapy for children with cancer. Pediatrics 95:896–900
Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL (2005) Cost-benefit analysis. In: Methods for the economic evaluation of health care program, 3rd edn, chapter 7. Oxford University Press, Oxford, pp 216
Inaba Y, Yamaura H, Sato Y et al (2007) Central venous access port-related complications in outpatient chemotherapy for colorectal cancer. Jpn J Clin Oncol 37(12):951–954
Isaac S, Michael WB (1997) Instrumentation and measurement. In: Handbook in research and evaluation for education and the behavioral sciences, 3rd edn, chapter 5. Educational and Industrial Testing Services, San Diego, pp 148
Kleeberg UR, Feyer P, Gunther W, Behrens M (2008) Patient satisfaction in outpatient cancer care: a prospective survey using the PASQOC questionnaire. Support Care Cancer 16:947–954
Korea Centers for Diseases Control and Prevention (2005) The third Korean National Health and Nutrition Examination Survey (KNHANES III). Ministry of Health, Welfare, and Family Affair, Seoul, Korea
Korean Ministry for Health, Welfare, and Family Affairs. National Cancer Management Project in 2004. http://www.mw.go.kr/front/jb/sjb030301vw.jsp?PAR_MENU_ID=03&MENU_ID=03030301&BOARD_ID=1003&BOARD_FLAG=02&CONT_SEQ=28526&page=1. Accessed 26 May 2009
Korea National Cancer Information Center. Incidence and prevalence of cancer. http://www.cancer.go.kr/cms/statics/stat/1215667_1611.html. Accessed 26 May 2009
Korean Statistical Information Service. Consumer price index. http://www.kosis.kr. Accessed 26 May 2009
Moalosi G, Floyd K, Phatshwane J, Moetl T, Binkin B, Kenyon T (2003) Cost-effectiveness of home-based care versus hospital care for chronically ill tuberculosis patients, Francistown, Botswana. Int J Tuberc Lung Dis 7(9):S80–S85
Moon JH, Kim JG, Sohn SK et al (2007) Outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer. J Korean Med Sci 22:400–404
Sato T, Kokuba Y, Ozawa H et al (2006) Outpatient chemotherapy of an advanced or metastatic colorectal cancer. Gan To Kagaku Ryoho 33(2):257–259, Japanese
Vokes EE, Schilsky RL, Choi KE et al (1989) A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced health and neck cancer. Cancer 63:30–36
WHO (1980) WHO handbook for reporting results of cancer treatment. Neoplasma 20:37–46
Zegarra RF 2nd, Saba AK, Peschiera JL (1997) Outpatient laparoscopic cholecystectomy: safe and cost-effective? Surg Laparosc Endosc 7(6):487–490
Author information
Authors and Affiliations
Corresponding author
Additional information
Eun-Hye Joo, M.S. contributed to the design of the study, developed the survey questionnaire, and collected and analyzed data.
Sun Young Rha, M.D. and Joong Bae Ahn, M.D contributed to clinical aspects of the study and reviewed the draft manuscript.
Hye-Young Kang, Ph.D. contributed to the design of the study, developed the survey questionnaire, interpreted the study results, and prepared the manuscript.
The English in this document has been checked by at least two professional editors, both native speakers of English. For a certificate, see: http://www.textcheck.com/certificate/wNekTw
Rights and permissions
About this article
Cite this article
Joo, EH., Rha, SY., Ahn, J.B. et al. Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer. Support Care Cancer 19, 971–978 (2011). https://doi.org/10.1007/s00520-010-0917-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-010-0917-7